Stay updated on Nivolumab With Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.

Latest updates to the Nivolumab With Azacitidine in AML Clinical Trial page
- Check3 days agoChange DetectedAdds new help and join-study sections such as How to Read a Study Record, Common Questions, and How to Join a Study, and adds a recruitment note indicating no participants are being sought. It also updates the Intervention heading formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision label from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check10 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new site revision. No study details or user-facing content are changed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, indicating a new release or update to the page’s underlying software. This change is administrative and does not modify the study content or visible details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now lists the updated protocol revision v3.5.3, replacing the previous v3.5.2. This indicates a new version of the study protocol document.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the page metadata.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab With Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.